系统性免疫炎症指数作为一种新的血液学标记,用于预测深静脉血栓的复发
Ibrahim Donmez1, Ayhan Muduroglu2
1Department of Cardiology, Faculty of Medicine, Bolu Abant Izzet Baysal University, Bolu, Turkey.
Vascular
|March 4, 2024
概括
系统性免疫炎症指数 (SII) 可以预测深静脉血栓 (DVT) 复发. 这项研究发现,SII是DVT复发的独立预测因素,为风险评估提供了一个新的工具.
科学领域:
- 血液学 血液学 血液学
- 心血管医学 心血管医学
- 免疫学 免疫学 免疫学
背景情况:
- 深静脉血栓症 (DVT) 是一种严重的血管疾病,具有复发风险.
- 确定DVT复发的可靠预测因素对于患者管理和风险分层至关重要.
研究的目的:
- 调查系统性免疫炎症指数 (SII) 对DVT复发的潜在预测价值.
- 确定SII是否作为DVT复发的独立预测因素.
主要方法:
- 一项回顾性横截面研究包括231名患有DVT的患者,分为复发组 (26名患者) 和对照组 (205名患者).
- 分析了包括SII在内的临床特征和全血细胞计 (CBC) 参数.
- 采用多变量逻辑回归和接收器操作特征 (ROC) 曲线分析来确定预测因素及其切断值.
主要成果:
- 系统性免疫炎症指数 (SII) 在经历了DVT复发的患者中显著更高.
- 多变量分析证实SII是DVT复发的重要和独立预测因素.
- 1685 × 10^3/mm^3的SII截止值显示了61.5%的灵敏度和76.6%的特异性来预测DVT复发 (AUC = 0.686).
结论:
- 系统性免疫炎症指数 (SII) 是深静脉血栓 (DVT) 复发的新且重要的预测指标.
- 在临床实践中,SII提供了一个有价值,易于获取的生物标志物,用于评估DVT复发的风险.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...


